newsfilter
← Latest News
GlobeNewswire·

T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- T2